tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Palvella Therapeutics (PVLA) Similar Stocks

Compare
634 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$23.82
$250.63M
174.48%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$4.89
$275.81M
-8.77%
2 Buy
0 Hold
0 Sell
Moderate Buy
Verastem
$4.85
$235.73M
64.97%
9 Buy
0 Hold
0 Sell
Strong Buy
Xoma
$26.11
$315.21M
0.81%
3 Buy
1 Hold
0 Sell
Strong Buy
Humacyte
$2.28
$353.67M
-59.26%
4 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$4.99
$258.62M
-20.92%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PVLA
Palvella Therapeutics
23.82
15.14
174.42%
VNDA
Vanda
4.89
-0.47
-8.77%
VSTM
Verastem
4.85
1.91
64.97%
XOMA
Xoma
26.11
0.21
0.81%
HUMA
Humacyte
2.31
-3.36
-59.26%
CADL
Candel Therapeutics
4.99
-1.32
-20.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis